CHOLESTOSOMES - Trademark Details
Status: 733 - Fourth Extension - Granted
Serial Number
88141769
Word Mark
CHOLESTOSOMES
Status
733 - Fourth Extension - Granted
Status Date
2021-11-04
Filing Date
2018-10-03
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-09-10
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
DUBOIS, SUSAN L
Statements
Goods and Services
Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of lipids, containing and facilitating the delivery of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of cholesteryl ester, containing and facilitating the delivery of pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non- alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and ankylosing spondylitis; and vaccines and vaccinations to prevent or treat infectious diseases and cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-10-12
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
R. Neil Sudol
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-10-06 | NEW APPLICATION ENTERED IN TRAM |
2018-10-12 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-01-15 | ASSIGNED TO EXAMINER |
2019-01-22 | NON-FINAL ACTION WRITTEN |
2019-01-22 | NON-FINAL ACTION E-MAILED |
2019-01-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-07-18 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-07-23 | ASSIGNED TO LIE |
2019-07-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-07-29 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-08-04 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-08-21 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-09-10 | PUBLISHED FOR OPPOSITION |
2019-09-10 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-11-05 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-04-17 | TEAS EXTENSION RECEIVED |
2020-04-17 | EXTENSION 1 FILED |
2020-04-17 | EXTENSION 1 GRANTED |
2020-04-21 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-05-01 | ASSIGNED TO EXAMINER |
2020-10-29 | TEAS EXTENSION RECEIVED |
2020-10-29 | EXTENSION 2 FILED |
2020-10-29 | EXTENSION 2 GRANTED |
2020-10-31 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-04-26 | TEAS EXTENSION RECEIVED |
2021-04-26 | EXTENSION 3 FILED |
2021-04-26 | EXTENSION 3 GRANTED |
2021-04-28 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-11-04 | TEAS EXTENSION RECEIVED |
2021-11-04 | EXTENSION 4 FILED |
2021-11-04 | EXTENSION 4 GRANTED |
2021-11-06 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2022-01-18 | ASSIGNED TO EXAMINER |